Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1 - Abstract

BACKGROUND:Prostate cancer is the most frequently diagnosed malignancy and the second-leading cause of cancer death in men.

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.
Tags:
Comments (0)
Only registered users can write comments!